gracecastuc-018_radiation_safely combine tarceva with brain radiation for lc brain metastases?
Published 11 years ago • 96 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
5:42
gracecastuc-006 - which patients with advanced lung cancer should potentially receive local therapy?
-
10:26
gracecast-121_rad_refining radiation therapy for lc, pt 1: a historical perspective, by dr. mehta
-
6:17
asco 2021 lung recap: immune therapy for brain metastases
-
4:51
gracecast-116_lung-cancer_asco 2012 lc highlights: dr. neal on select trial of tarceva (erlotinib)
-
5:51
gracecast-126_rad_refining radiation therapy for lung cancer, part 6: metastatic lung cancer
-
6:41
gracecast-123_rad_refining radiation therapy for lc, pt 3: recent successes and open questions
-
3:30
2020 peaprogram breast cancer series patients with brain metastases - prognosis & impact on survival
-
0:23
cancer awareness april #youtubeshorts #shorts
-
6:43
using radiation therapy in metastatic lung cancer: an overview - onctalk lung 2023
-
8:14
gracecast-048_lung-cancer_expert round table - tsao & farivar case 3
-
2:31
gracecastuc-004 - why is chemotherapy recommended for most patients with nsclc?
-
10:08
gracecast-042_cancer-101_challenges in cancer imaging
-
2:00
gracecastuc-001 - intro to casual video gracecasts, the uncut series
-
3:14
stereotactic body radiotherapy (sbrt) for oligoprogressive nsclc - onctalk lung 2023
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
3:03
stereotactic body radiation therapy (sbrt) for medically inoperable early stage lung cancer
-
10:57
gracecast-125_rad_refining radiation therapy for lung cancer, part 5: new techniques
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
6:38
gracecastuc-005 - the topical study: is rash a predictor of benefit with egfr inhibitor therapy?